|
Dear Colleagues, Welcome to the first edition of the Division of Infectious Disease and International Medicine e-newsletter for January 2008.
W Robert C. Moellering, Jr, MD is the Herrman L. Blumgart Professor of Medicine at Harvard Medical School and Physician-in-Chief and Chairman of the Department of Medicine at the Beth Israel Deaconess Medical Center, Boston, Massachusetts. He serves as president and CEO of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (BIDMC). His research work includes studies of the mechanism of action and mechanisms of resistance to antimicrobial agents. He has defined the important mechanisms of interaction of antimicrobial agents, particularly against the enterococcus which has been a particular investigative interest for many years. He was the first to define the clinical utility of penicillin/gentamicin therapy for enterococcal endocarditis and he and his laboratory colleagues have defined many of the important mechanisms of resistance to antimicrobial agents in this increasingly important organism. More recently he has been investigating the mechanisms of resistance to vancomycin and oxazolidinones in Staphylococcus aureus and the basis for pathogenesis in enterococci and staphylococci. His work is reported in over 350 publications in scientific journals. | |
![]() |
|
|
|
Warmly,
John Sinnott MD FACP View our E-Newsletter archive to get up to date on what's happening in the ID Division. |





